Tianjin Tianyao Pharmaceuticals Co., Ltd.
FDA Approved Drugs

Tianjin Tianyao Pharmaceuticals Co., Ltd.

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 10
  • Latest Approval Date Apr 20, 2021
  • Data Source FDA
  • First Approval Date May 14, 2018
Company Overview

Company

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Country

China

Website

Visit Website

Email

lixm1@tjpc.com.cn

Social Profiles

Company Snapshot

Tianjin Tianyao Pharmaceuticals Co., Ltd.

No.19, XINYE 9th Street, West Area of Tianjin Economic-Technological Development Area (TEDA), Tianjin  300 462

China

www.tjpc.com.cn/ lixm1@tjpc.com.cn View on Map
FDA Approved Drug Records ( 10 records )
2020
25 Feb
RX Application: 207872

Drug Name

CELECOXIB

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2020-02-25

207872 / 1

Active Ingredient

CELECOXIB

Application Number

207872

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2020-02-25

Regulatory Status

RX

2020
25 Feb
RX Application: 207872

Drug Name

CELECOXIB

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2020-02-25

207872 / 2

Active Ingredient

CELECOXIB

Application Number

207872

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2020-02-25

Regulatory Status

RX

2020
25 Feb
RX Application: 207872

Drug Name

CELECOXIB

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2020-02-25

207872 / 3

Active Ingredient

CELECOXIB

Application Number

207872

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2020-02-25

Regulatory Status

RX

2020
25 Feb
RX Application: 207872

Drug Name

CELECOXIB

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

2020-02-25

207872 / 4

Active Ingredient

CELECOXIB

Application Number

207872

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

2020-02-25

Regulatory Status

RX

2018
14 May
RX Application: 204072

Drug Name

METHYLPREDNISOLONE

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

2018-05-14

204072 / 1

Active Ingredient

METHYLPREDNISOLONE

Application Number

204072

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

2018-05-14

Regulatory Status

RX

2021
20 Apr
RX Application: 212396

Drug Name

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2021-04-20

212396 / 1

Active Ingredient

METHYLPREDNISOLONE SODIUM SUCCINATE

Application Number

212396

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2021-04-20

Regulatory Status

RX

2021
20 Apr
RX Application: 212396

Drug Name

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 125MG BASE/VIAL

Approval Date

2021-04-20

212396 / 2

Active Ingredient

METHYLPREDNISOLONE SODIUM SUCCINATE

Application Number

212396

Product Number

2

Dosage Form

-

Strength

EQ 125MG BASE/VIAL

Approval Date

2021-04-20

Regulatory Status

RX

2021
20 Apr
RX Application: 212396

Drug Name

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Number

3

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2021-04-20

212396 / 3

Active Ingredient

METHYLPREDNISOLONE SODIUM SUCCINATE

Application Number

212396

Product Number

3

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2021-04-20

Regulatory Status

RX

2021
20 Apr
RX Application: 212396

Drug Name

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Number

4

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2021-04-20

212396 / 4

Active Ingredient

METHYLPREDNISOLONE SODIUM SUCCINATE

Application Number

212396

Product Number

4

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2021-04-20

Regulatory Status

RX

2021
20 Apr
RX Application: 212396

Drug Name

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Number

5

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2021-04-20

212396 / 5

Active Ingredient

METHYLPREDNISOLONE SODIUM SUCCINATE

Application Number

212396

Product Number

5

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2021-04-20

Regulatory Status

RX

Related Databases
  • FDA Inspections
    6 View
  • EDQM CEP
    20 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    11 View
  • FDA Approved Drugs Database
    10 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
10 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

CELECOXIB

Application Number

207872

Product Number

1

Active Ingredient

CELECOXIB

Dosage Form

-

Strength

50MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit